Medco Personalized Medicine Research Shows “Real World” Promise – Frueh
Executive Summary
Medco's research can advance the cause of personalized medicine by proving its benefits in a "real world" setting, according to Felix Frueh, the firm's new VP of research and development for personalized medicine
You may also be interested in...
Genomic Updates To Drug Labeling Could Result From Medco/FDA Partnership
FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information. Announced by Medco on Aug. 18, the project calls for the pharmacy benefit management company to draw from its pharmacy claims data base and its own physician and member surveys to produce a series of reports on the impact of genetic testing on drug efficacy and safety
Genomic Updates To Drug Labeling Could Result From Medco/FDA Partnership
FDA could use results from a new research collaboration with Medco to update existing drug labeling with genomic information. Announced by Medco on Aug. 18, the project calls for the pharmacy benefit management company to draw from its pharmacy claims data base and its own physician and member surveys to produce a series of reports on the impact of genetic testing on drug efficacy and safety
Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research
Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16